AU3057299A - Sustained-release composition containing cefaclor - Google Patents

Sustained-release composition containing cefaclor

Info

Publication number: AU3057299A
Authority: AU; Australia
Prior art keywords: sustained; composition containing; release composition; containing cefaclor; cefaclor
Prior art date: 1998-04-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU30572/99A

Inventor

Hyun Soo Kim

Young Joon Park

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Yuhan Corp

Original Assignee

Yuhan Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-01

Filing date

1999-04-01

Publication date

1999-10-18

1999-04-01 Application filed by Yuhan Corp filed Critical Yuhan Corp

1999-10-18 Publication of AU3057299A publication Critical patent/AU3057299A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Inorganic Chemistry (AREA)
Communicable Diseases (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU30572/99A 1998-04-01 1999-04-01 Sustained-release composition containing cefaclor Abandoned AU3057299A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
KR1019980011397A KR100296413B1 (en)	1998-04-01	1998-04-01	Sustained released tablet containing cefaclor
KR9811397		1998-04-01
PCT/KR1999/000159 WO1999049868A1 (en)	1998-04-01	1999-04-01	Sustained-release composition containing cefaclor

Publications (1)

Publication Number	Publication Date
AU3057299A true AU3057299A (en)	1999-10-18

Family

ID=19535690

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU30572/99A Abandoned AU3057299A (en)	1998-04-01	1999-04-01	Sustained-release composition containing cefaclor

Country Status (6)

Country	Link
EP (1)	EP1067937A1 (en)
JP (1)	JP2002509887A (en)
KR (1)	KR100296413B1 (en)
CN (1)	CN1151791C (en)
AU (1)	AU3057299A (en)
WO (1)	WO1999049868A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1318495B1 (en) *	2000-05-04	2003-08-25	Lisapharma Spa	PHARMACEUTICAL FORMULATIONS, WITH MODIFIED RELEASE, WITH HIGH AVAILABILITY, CONTAINING ACTIVE INGREDIENTS IN ACTIVITIES
ATE510533T1 (en) *	2000-06-21	2011-06-15	Cubist Pharm Inc	MEDICINAL COMPOSITIONS AND METHODS FOR IMPROVING ORAL ABSORPTION OF ANTIMICROBIAL ACTIVES
US7527807B2 (en)	2000-06-21	2009-05-05	Cubist Pharmaceuticals, Inc.	Compositions and methods for increasing the oral absorption of antimicrobials
KR20040043589A (en) *	2002-11-19	2004-05-24	경동제약 주식회사	Slow releasable drugs containing cefarclor as a effective ingredient and preparing method thereof
US7919483B2 (en) *	2005-06-24	2011-04-05	Medicis Pharmaceutical Corporation	Method for the treatment of acne
US8722650B1 (en)	2005-06-24	2014-05-13	Medicis Pharmaceutical Corporation	Extended-release minocycline dosage forms
KR100683193B1 (en) *	2005-07-30	2007-02-15	주식회사유한양행	Process for preparing diclazuryl-containing pharmaceutical composition
TR201000688A2 (en) *	2010-01-29	2011-08-22	B�Lg�� Mahmut	Effervescent formulations containing cefaclor and clavulanic acid as active ingredient.
EP2361615A1 (en) *	2010-02-19	2011-08-31	Alfred E. Tiefenbacher GmbH & Co. KG	Dipyridamole prolonged-release tablet
WO2012169677A1 (en) *	2011-06-09	2012-12-13	주식회사 비씨월드제약	Composition for controlling gastric retention and release
US9561241B1 (en)	2011-06-28	2017-02-07	Medicis Pharmaceutical Corporation	Gastroretentive dosage forms for minocycline
EP3031847A1 (en)	2014-12-11	2016-06-15	Solvay Acetow GmbH	Polymer composition comprising basic additive, process and articles comprising said polymer composition
CN104688701A (en) *	2015-03-20	2015-06-10	江苏亚邦强生药业有限公司	Cefaclor tablet and preparation method thereof
CN114097939B (en) *	2021-11-19	2024-04-16	上海佩格医院管理有限公司	Sustained release tablet matrix and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS601128A (en) *	1983-06-15	1985-01-07	Shionogi & Co Ltd	Long-acting cefaclor preparation
JPS62195323A (en) *	1986-02-24	1987-08-28	Eisai Co Ltd	Gastric resident particle
CA1316110C (en) *	1987-02-27	1993-04-13	Peter Lloyd Oren	Sustained release matrix formulations

1998
- 1998-04-01 KR KR1019980011397A patent/KR100296413B1/en not_active IP Right Cessation
1999
- 1999-04-01 JP JP2000540831A patent/JP2002509887A/en active Pending
- 1999-04-01 AU AU30572/99A patent/AU3057299A/en not_active Abandoned
- 1999-04-01 CN CNB998068233A patent/CN1151791C/en not_active Expired - Fee Related
- 1999-04-01 EP EP99912140A patent/EP1067937A1/en not_active Withdrawn
- 1999-04-01 WO PCT/KR1999/000159 patent/WO1999049868A1/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1067937A1 (en)	2001-01-17
KR19990079034A (en)	1999-11-05
WO1999049868A1 (en)	1999-10-07
JP2002509887A (en)	2002-04-02
CN1151791C (en)	2004-06-02
CN1303291A (en)	2001-07-11
KR100296413B1 (en)	2001-11-14

Publication	Publication Date	Title
EG24412A (en)	2009-05-25	Novel compounds
EG24177A (en)	2008-09-28	Novel compounds
GB9701684D0 (en)	1997-03-19	Novel compounds
AU7210598A (en)	1998-10-20	Novel compounds
AU6804098A (en)	1998-11-26	Triazinylaminostilbene compounds
AU4260199A (en)	1999-11-29	Novel compounds
AU5980899A (en)	2000-04-17	Novel compounds
AU5335798A (en)	1999-05-10	Stomatic composition
AU2014800A (en)	2000-06-26	Novel compounds
AU3057299A (en)	1999-10-18	Sustained-release composition containing cefaclor
AU8747498A (en)	1999-03-16	Food-preservative composition
AU7476598A (en)	1999-02-10	18-substituted-19-nor-vitamin d compounds
AUPO941497A0 (en)	1997-10-16	Novel compounds
AUPP042397A0 (en)	1997-12-11	5-arylpyrazole compounds
AU4814699A (en)	2000-01-10	Novel compounds
AU8121998A (en)	1999-01-25	Composition
AU7124598A (en)	1998-11-13	Polymer-platinum compounds
AU699057B2 (en)	1998-11-19	Chemical composition
AU1098499A (en)	1999-05-10	Emulsifier-lipid composition
AU8863098A (en)	1999-02-16	Chemical composition
AU2187799A (en)	1999-08-09	Novel taxaneterpine compounds
AU8019998A (en)	1998-12-21	Fluoromethoximino compounds
AU9753998A (en)	1999-05-24	Azaboroxine compounds
AU7041098A (en)	1998-10-30	Pi-complex compounds
AU1192300A (en)	2000-04-17	Novel compounds

Legal Events

Date	Code	Title	Description
2000-12-14	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase